IQVIA Holdings Basic Shares Outstanding 2011-2025 | IQV
IQVIA Holdings annual/quarterly basic shares outstanding history and growth rate from 2011 to 2025. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
- IQVIA Holdings basic shares outstanding for the quarter ending March 31, 2025 were $0.176B, a 3.41% decline year-over-year.
- IQVIA Holdings basic shares outstanding for the twelve months ending March 31, 2025 were $0.721B, a 1.6% decline year-over-year.
- IQVIA Holdings annual basic shares outstanding for 2024 were $0.181B, a 1.36% decline from 2023.
- IQVIA Holdings annual basic shares outstanding for 2023 were $0.184B, a 2.03% decline from 2022.
- IQVIA Holdings annual basic shares outstanding for 2022 were $0.188B, a 1.99% decline from 2021.
| IQVIA Holdings Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $181 |
| 2023 | $184 |
| 2022 | $188 |
| 2021 | $191 |
| 2020 | $191 |
| 2019 | $195 |
| 2018 | $204 |
| 2017 | $218 |
| 2016 | $149 |
| 2015 | $123 |
| 2014 | $128 |
| 2013 | $124 |
| 2012 | $116 |
| 2011 | $116 |
| 2010 | $116 |
| IQVIA Holdings Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2025-03-31 | $176 |
| 2024-12-31 | $181 |
| 2024-09-30 | $182 |
| 2024-06-30 | $182 |
| 2024-03-31 | $182 |
| 2023-12-31 | $184 |
| 2023-09-30 | $183 |
| 2023-06-30 | $184 |
| 2023-03-31 | $186 |
| 2022-12-31 | $188 |
| 2022-09-30 | $187 |
| 2022-06-30 | $188 |
| 2022-03-31 | $190 |
| 2021-12-31 | $191 |
| 2021-09-30 | $192 |
| 2021-06-30 | $192 |
| 2021-03-31 | $192 |
| 2020-12-31 | $191 |
| 2020-09-30 | $191 |
| 2020-06-30 | $191 |
| 2020-03-31 | $192 |
| 2019-12-31 | $195 |
| 2019-09-30 | $195 |
| 2019-06-30 | $196 |
| 2019-03-31 | $197 |
| 2018-12-31 | $204 |
| 2018-09-30 | $202 |
| 2018-06-30 | $206 |
| 2018-03-31 | $208 |
| 2017-12-31 | $218 |
| 2017-09-30 | $214 |
| 2017-06-30 | $218 |
| 2017-03-31 | $230 |
| 2016-12-31 | $149 |
| 2016-09-30 | $119 |
| 2016-06-30 | $120 |
| 2016-03-31 | $119 |
| 2015-12-31 | $123 |
| 2015-09-30 | $123 |
| 2015-06-30 | $124 |
| 2015-03-31 | $125 |
| 2014-12-31 | $128 |
| 2014-09-30 | $127 |
| 2014-06-30 | $129 |
| 2014-03-31 | $130 |
| 2013-12-31 | $124 |
| 2013-09-30 | $129 |
| 2013-06-30 | $123 |
| 2013-03-31 | $116 |
| 2012-12-31 | $116 |
| 2012-09-30 | $116 |
| 2012-06-30 | $116 |
| 2012-03-31 | $116 |
| 2011-12-31 | |
| 2010-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $25.587B | $15.405B |
| IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.979B | 87.59 |
| Thermo Fisher Scientific (TMO) | United States | $152.379B | 18.43 |
| Edwards Lifesciences (EW) | United States | $45.667B | 29.94 |
| Alcon (ALC) | Switzerland | $42.389B | 28.65 |
| IDEXX Laboratories (IDXX) | United States | $42.210B | 48.51 |
| DexCom (DXCM) | United States | $33.568B | 51.88 |
| Mettler-Toledo (MTD) | United States | $24.309B | 28.91 |
| STERIS (STE) | Ireland | $23.816B | 26.23 |
| Waters (WAT) | United States | $21.016B | 29.65 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.484B | 0.00 |
| Hologic (HOLX) | United States | $13.943B | 15.15 |
| Sysmex ADR (SSMXY) | Japan | $10.323B | 29.29 |
| Penumbra (PEN) | United States | $9.888B | 77.61 |
| Masimo (MASI) | United States | $8.836B | 32.59 |
| Globus Medical (GMED) | United States | $8.077B | 19.25 |
| Teleflex (TFX) | United States | $5.424B | 8.95 |
| Glaukos (GKOS) | United States | $5.198B | 0.00 |
| TransMedics (TMDX) | United States | $4.391B | 95.45 |
| Integer Holdings (ITGR) | United States | $4.193B | 21.97 |
| PROCEPT BioRobotics (PRCT) | United States | $3.410B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.425B | 14.44 |
| Nihon Kohden (NHNKY) | Japan | $2.244B | 25.74 |
| Veracyte (VCYT) | United States | $2.137B | 29.99 |
| Elekta AB (EKTAY) | Sweden | $1.968B | 17.69 |
| Alphatec Holdings (ATEC) | United States | $1.795B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.344B | 0.00 |
| Artivion (AORT) | United States | $1.224B | 114.64 |
| Pulse Biosciences (PLSE) | United States | $1.181B | 0.00 |
| OPKO Health (OPK) | United States | $1.067B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.018B | 5.41 |
| Beta Bionics (BBNX) | United States | $0.843B | 0.00 |
| SiBone (SIBN) | United States | $0.788B | 0.00 |
| IRadimed (IRMD) | United States | $0.773B | 39.21 |
| RxSight (RXST) | United States | $0.620B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.577B | 8.97 |
| Delcath Systems (DCTH) | United States | $0.570B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.551B | 12.91 |
| AxoGen (AXGN) | United States | $0.496B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.489B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.445B | 0.00 |
| NeuroPace (NPCE) | United States | $0.432B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.427B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.399B | 10.61 |
| ClearPoint Neuro (CLPT) | United States | $0.364B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.363B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.309B | 0.00 |
| Neuronetics (STIM) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.247B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.28 |
| Sight Sciences (SGHT) | United States | $0.219B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.207B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Accuray (ARAY) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.159B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.157B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.156B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.132B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.100B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.080B | 48.90 |
| InspireMD (NSPR) | United States | $0.080B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.055B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| Spectral AI (MDAI) | United States | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.030B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.12 |